Metacognitive Therapy for Obsessive-Compulsive Disorder

Last updated: June 17, 2024
Sponsor: Northeast Normal University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Obsessive-compulsive Disorder

Anxiety Disorders

Panic Disorders

Treatment

Metacognitive Therapy

General mental health promotion

Clinical Study ID

NCT06466057
NENU2023032
  • Ages 12-60
  • All Genders

Study Summary

The goal of this clinical trial is to learn if metacognitive therapy can be effective in a Chinese sample of obsessive compulsive disorder (OCD) . The main questions it aims to answer are:

Can metacognitive therapy significantly reduce participants' levels of obsessive-compulsive symptoms? Can metacognitive therapy significantly improve participants' metacognitive adaptations?

The researchers will compare metacognitive therapy to a control condition without psychotherapy to see if metacognitive therapy is effective in treating OCD.

Participants will:

Receive the metacognitive therapy intervention or under control conditions for 8 to 15 weeks.

Be assessed for symptoms and metacognitive beliefs at pre-intervention, post-intervention and 12 weeks post-intervention

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • two psychiatrists with the title of Deputy Chief Physician or above jointlydetermine that the above diagnostic criteria were met

  • education level of junior high school or above, without mental retardation oraudio-visual disorders

  • participation in the study is voluntary, and the informed consent is signed by thepatient or his/her guardian

Exclusion

Exclusion Criteria:

  • loss of or insufficient self-awareness, the presence of hallucinations, delusions,and other psychotic symptoms

  • the presence of severe depression, or self-inflicted suicidal attempts and behaviors

  • the presence of a history of alcohol or drug abuse

  • refusal of psychotherapy, or the ineffectiveness of those who had been involved in afull course of psychotherapy.

Study Design

Total Participants: 80
Treatment Group(s): 2
Primary Treatment: Metacognitive Therapy
Phase:
Study Start date:
June 11, 2024
Estimated Completion Date:
November 01, 2024

Study Description

This study will be a randomised controlled clinical trial. Participants who meet the enrolment criteria will be randomised into an experimental group and a control group. Participants in the experimental group will receive 8-15 weeks of metacognitive therapy, while participants in the control group will receive the same amount of time of regular treatment without psychotherapy components.

The researchers will assess participants' obsessive-compulsive symptoms and metacognitive levels before, after, and 12 weeks after the intervention. Assessment measures will be the Yale Brown Obsessive-Compulsive Scale (Y-BOCS) and the Metacognition Questionnaire (MCQ-30).

By comparing the assessment results of the two groups of participants, conclusions will be drawn as to whether metacognitive therapy can have a positive effect on a Chinese OCD sample.

Connect with a study center

  • Northeast Normal University

    Changchun, Jilin 0431
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.